|
|
|
|
|
|
|
|
131st MAINE LEGISLATURE |
|
|
LD 1395 |
|
LR 1620(01) |
|
|
|
An Act to Increase
Transparency Regarding Certain Drug Pricing Programs |
|
Preliminary Fiscal
Impact Statement for Original Bill |
|
Sponsor: Sen. Tipping of Penobscot |
|
Committee: Health Coverage, Insurance and
Financial Services |
|
Fiscal Note Required: No |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preliminary
Fiscal Impact Statement |
|
|
|
|
|
|
|
| Minor cost increase - General Fund |
|
|
|
|
|
|
|
| Fiscal Detail
and Notes |
|
|
|
|
|
|
Additional costs
to the Maine Health Data Organization associated with summarizing and posting
reports from hospitals that participate in certain prescription drug pricing
programs are expected to be minor and can be absorbed within existing
budgeted resources. |
|
|
|
|
|
|
|